Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D


Journal

Molecular imaging and biology
ISSN: 1860-2002
Titre abrégé: Mol Imaging Biol
Pays: United States
ID NLM: 101125610

Informations de publication

Date de publication:
04 2021
Historique:
received: 19 06 2020
accepted: 03 11 2020
revised: 29 10 2020
pubmed: 13 11 2020
medline: 16 11 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

Our aim in this study was to compare different non-invasive pharmacokinetic models and assess test-retest reproducibility of the radioligand [ Adult WT (n = 9) and HET (n = 14) mice underwent a 90-min [ For all models, we measured a significant decline in dopamine D Ninety-minute acquisition and the use of SRTM for pharmacokinetic modelling is recommended. [

Identifiants

pubmed: 33179158
doi: 10.1007/s11307-020-01561-1
pii: 10.1007/s11307-020-01561-1
pmc: PMC7910372
doi:

Substances chimiques

Benzazepines 0
Carbon Radioisotopes 0
Carbon-11 0
Receptors, Dopamine D1 0
SCH 23390 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-219

Références

PLoS One. 2012;7(12):e49838
pubmed: 23284626
Mol Imaging Biol. 2020 Aug;22(4):854-863
pubmed: 31792838
J Nucl Med. 1998 May;39(5):792-7
pubmed: 9591577
Front Neural Circuits. 2013 Oct 11;7:152
pubmed: 24130517
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8861-5
pubmed: 8415621
Mol Neurobiol. 2020 Apr;57(4):2038-2047
pubmed: 31912442
Eur J Pharmacol. 1992 Aug 14;219(1):45-52
pubmed: 1397049
J Huntingtons Dis. 2014;3(4):333-41
pubmed: 25575954
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1025-1032
pubmed: 28197685
Psychopharmacology (Berl). 1993;113(2):149-56
pubmed: 7855175
Eur J Pharmacol. 1988 Jan 27;146(1):113-20
pubmed: 2895008
J Cereb Blood Flow Metab. 2001 Oct;21(10):1146-50
pubmed: 11598491
Biomed Res Int. 2013;2013:808713
pubmed: 24083242
J Cereb Blood Flow Metab. 2002 Dec;22(12):1440-52
pubmed: 12468889
J Neurochem. 1985 Nov;45(5):1601-11
pubmed: 2864398
J Neurosci. 2002 May 1;22(9):3708-19
pubmed: 11978847
Prog Brain Res. 2014;211:235-54
pubmed: 24968783
EJNMMI Res. 2018 Aug 2;8(1):74
pubmed: 30069645
Mol Imaging Biol. 2018 Feb;20(1):114-123
pubmed: 28631142
IEEE Trans Med Imaging. 2020 Jul;39(7):2518-2530
pubmed: 32070945
Curr Opin Investig Drugs. 2001 Nov;2(11):1582-91
pubmed: 11763161
Int J Rad Appl Instrum A. 1986;37(10):1039-43
pubmed: 3027000
PLoS One. 2012;7(12):e50717
pubmed: 23284644
J Cereb Blood Flow Metab. 2020 Jun;40(6):1351-1362
pubmed: 31307287
PLoS One. 2013 Jul 23;8(7):e69782
pubmed: 23936100
J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112
pubmed: 12973026
Neuropsychopharmacology. 1994 Dec;11(4):245-56
pubmed: 7531978
J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
pubmed: 8784228
Psychopharmacology (Berl). 2013 Jul;228(1):167-74
pubmed: 23460265
Neuroscientist. 2003 Oct;9(5):404-16
pubmed: 14580124
PLoS One. 2016 Feb 09;11(2):e0148839
pubmed: 26859386
Neurobiol Dis. 2010 Feb;37(2):356-61
pubmed: 19853661
Brain. 1997 Mar;120 ( Pt 3):503-14
pubmed: 9126061
Brain. 1999 Dec;122 ( Pt 12):2353-63
pubmed: 10581228
Neurosci Lett. 1988 Aug 31;91(2):142-7
pubmed: 2972942
Psychopharmacology (Berl). 1987;92(3):278-84
pubmed: 2957716
Brain. 1995 Jun;118 ( Pt 3):689-96
pubmed: 7600086
Ann Neurol. 1996 Jul;40(1):49-54
pubmed: 8687191
Neuroimage. 1997 Nov;6(4):279-87
pubmed: 9417971
J Nucl Med. 2016 May;57(5):792-8
pubmed: 26912432
Mol Imaging Biol. 2007 May-Jun;9(3):117-25
pubmed: 17473957
PLoS One. 2018 Oct 26;13(10):e0206613
pubmed: 30365550
Neuroscience. 2006 Apr 28;139(1):263-76
pubmed: 16310964
J Nucl Med. 1998 Dec;39(12):2061-8
pubmed: 9867142
PLoS One. 2018 Aug 17;13(8):e0200626
pubmed: 30118496
Pharmacol Ther. 2010 Oct;128(1):37-60
pubmed: 20547182
Mol Psychiatry. 2000 Nov;5(6):664-72
pubmed: 11126397
Neuroimage. 1996 Dec;4(3 Pt 1):153-8
pubmed: 9345505
J Neurophysiol. 2015 Apr 1;113(7):2953-66
pubmed: 25673747
J Pharmacol Exp Ther. 1992 Mar;260(3):1361-5
pubmed: 1347569
J Cereb Blood Flow Metab. 2010 May;30(5):985-93
pubmed: 20029452
J Nucl Med. 2017 Apr;58(4):617-622
pubmed: 27856625
J Cereb Blood Flow Metab. 2007 Oct;27(10):1733-41
pubmed: 17311076
Synapse. 1998 Sep;30(1):56-61
pubmed: 9704881
J Nucl Med. 2013 Jul;54(7):1127-34
pubmed: 23729696

Auteurs

Daniele Bertoglio (D)

Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium.

Jeroen Verhaeghe (J)

Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium.

Alan Miranda (A)

Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium.

Leonie Wyffels (L)

Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium.
Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.

Sigrid Stroobants (S)

Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium.
Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.

Celia Dominguez (C)

CHDI Management/CHDI Foundation, Los Angeles, CA, USA.

Ignacio Munoz-Sanjuan (I)

CHDI Management/CHDI Foundation, Los Angeles, CA, USA.

Mette Skinbjerg (M)

CHDI Management/CHDI Foundation, Los Angeles, CA, USA.

Longbin Liu (L)

CHDI Management/CHDI Foundation, Los Angeles, CA, USA.

Steven Staelens (S)

Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium. steven.staelens@uantwerpen.be.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH